The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Nrf2 Protects Against Maladaptive Cardiac Responses to Hemodynamic Stress
Open accessAbstract
Background— Reactive oxygen species (ROS) play an important role in the maintenance of cardiovascular homeostasis. The present study sought to determine whether nuclear factor erythroid-2 related factor 2 (Nrf2), a master gene of the endogenous antioxidant defense system, is a critical regulator of the cardiac hypertrophic response to pathological stress. Methods and Results— Cardiac hypertrophy and dysfunction were established in mice by transverse aortic constriction (TAC). Nrf2 expression was transiently increased and then declined to the basal level while impairment of cardiac function proceeded. The knockout of Nrf2 (Nrf2 −/− ) did not cause any apparent structural and functional abnormalities in the unstressed heart. However, Nrf2 −/− mice after TAC developed pathological cardiac hypertrophy, significant myocardial fibrosis and apoptosis, overt heart failure, and increased mortality, which were associated with elevated myocardial levels of 4-hydroxy-2-nonenal and 8-hydroxydeoxyguanosine and a complete blockade of the myocardial expression of several antioxidant genes. Overexpression of Nrf2 dramatically inhibited hypertrophic factor–induced ROS production and growth in both cardiomyocytes and cardiac fibroblasts, whereas knockdown of Nrf2 exerted opposite effects in both cells. Conclusions— These findings demonstrate that activation of Nrf2 provides a novel mechanism to protect the murine heart against pathological cardiac hypertrophy and heart failure via suppressing oxidative stress.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Rockman, H. A., Ross, R. S., Harris, A. N., Knowlton, K. U., Steinhelper, M. E., Field, L. J., Ross, J., & Chien, K. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.18.8277 · Cited by 797
RetractedA new mathematical model for relative quantification in real-time RT-PCR
Pfaffl, M. W. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.9.e45 · Cited by 34,610
Sahn, D. J., DeMaria, A., Kisslo, J., & Weyman, A. (1978) · Circulation · doi:10.1161/01.cir.58.6.1072 · Cited by 7,430
Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6943 · Cited by 3,999
Writing Group Members, Rosamond, W., Flegal, K., Furie, K., Go, A., Greenlund, K., Haase, N., Hailpern, S. M., Ho, M., Howard, V., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.187998 · Cited by 3,711
Cell Survival Responses to Environmental Stresses Via the Keap1-Nrf2-ARE Pathway
Kensler, T. W., Wakabayashi, N., & Biswal, S. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141046 · Cited by 3,630
Regulation of cardiac hypertrophy by intracellular signalling pathways
Heineke, J., & Molkentin, J. D. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1983 · Cited by 1,866
Oxidative Stress and Vascular Disease
Madamanchi, N. R., Vendrov, A., & Runge, M. S. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000150649.39934.13 · Cited by 1,618 · cited 1×
“20 (6) B C 4 Arterioscler Thromb Vasc Biol September 2009”
Inflammatory Cytokines and Postmyocardial Infarction Remodeling
Nian, M., Lee, P., Khaper, N., & Liu, P. (2004) · Circulation Research · doi:10.1161/01.res.0000130526.20854.fa · Cited by 1,028
p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload
Sano, M., Minamino, T., Toko, H., Miyauchi, H., Orimo, M., Qin, Y., Akazawa, H., Tateno, K., Kayama, Y., Harada, M., et al. (2007) · Nature · doi:10.1038/nature05602 · Cited by 905
ECM remodeling in hypertensive heart disease
Berk, B. C., Fujiwara, K., & Lehoux, S. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31044 · Cited by 902
Kobayashi, M., & Yamamoto, M. (2006) · Advances in Enzyme Regulation · doi:10.1016/j.advenzreg.2006.01.007 · Cited by 856
Self-citationRole of Oxidative Stress in Cardiac Hypertrophy and Remodeling
Takimoto, E., & Kass, D. A. (2007) · Hypertension · doi:10.1161/01.hyp.0000254415.31362.a7 · Cited by 770
A mechanistic role for cardiac myocyte apoptosis in heart failure
Wencker, D., Chandra, M., Nguyen, K., Miao, W., Garantziotis, S., Factor, S. M., Shirani, J., Armstrong, R. C., & Kitsis, R. N. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17664 · Cited by 765
Gene Expression in Fibroblasts and Fibrosis: Involvement in Cardiac Hypertrophy
Manabe, I., Shindo, T., & Nagai, R. (2002) · Circulation Research · doi:10.1161/01.res.0000046452.67724.b8 · Cited by 512
Simpson, P., McGrath, A., & Savion, S. (1982) · Circulation Research · doi:10.1161/01.res.51.6.787 · Cited by 426
Sorescu, D., & Griendling, K. K. (2002) · Congestive Heart Failure · doi:10.1111/j.1527-5299.2002.00717.x · Cited by 406
Zhu, H., Itoh, K., Yamamoto, M., Zweier, J. L., & Li, Y. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.04.058 · Cited by 393
Self-citationDeterminants of ventricular function in pressure-overload hypertrophy in man.
Gunther, S., & Grossman, W. (1979) · Circulation · doi:10.1161/01.cir.59.4.679 · Cited by 350
Yoh, K., Itoh, K., Enomoto, A., Hirayama, A., Yamaguchi, N., Kobayashi, M., Morito, N., Koyama, A., Yamamoto, M., & Takahashi, S. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00939.x · Cited by 344
Self-citationNADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure
MURDOCH, C., ZHANG, M., CAVE, A., & SHAH, A. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.03.016 · Cited by 343
Gutierrez, J., Ballinger, S. W., Darley-Usmar, V. M., & Landar, A. (2006) · Circulation Research · doi:10.1161/01.res.0000248212.86638.e9 · Cited by 318
Sano, M., Fukuda, K., Sato, T., Kawaguchi, H., Suematsu, M., Matsuda, S., Koyasu, S., Matsui, H., Yamauchi-Takihara, K., Harada, M., et al. (2001) · Circulation Research · doi:10.1161/hh2001.098873 · Cited by 298
Toward transcriptional therapies for the failing heart: chemical screens to modulate genes
McKinsey, T. A., & Olson, E. N. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524144 · Cited by 288
Ma, Q., Battelli, L., & Hubbs, A. F. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.051113 · Cited by 244
Vascular NADPH oxidases as drug targets for novel antioxidant strategies
Guzik, T. J., & Harrison, D. G. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.04.003 · Cited by 235
Antioxidants and Atherosclerosis: Don’t Throw Out the Baby With the Bath Water
Jialal, I., & Devaraj, S. (2003) · Circulation · doi:10.1161/01.cir.0000048966.26216.4c · Cited by 208
Walters, D. M., Cho, H.-Y., & Kleeberger, S. R. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1901 · Cited by 206
Sam, F., Kerstetter, D. L., Pimental, D. R., Mulukutla, S., Tabaee, A., Bristow, M. R., Colucci, W. S., & Sawyer, D. B. (2005) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2005.01.007 · Cited by 195
Badorff, C., Ruetten, H., Mueller, S., Stahmer, M., Gehring, D., Jung, F., Ihling, C., Zeiher, A. M., & Dimmeler, S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci13779 · Cited by 174
Genetic dissection of systemic autoimmune disease in Nrf2-deficient mice
Li, J., Stein, T. D., & Johnson, J. A. (2004) · Physiological Genomics · doi:10.1152/physiolgenomics.00209.2003 · Cited by 161
Self-citation1-Adrenergic receptors prevent a maladaptive cardiac response to pressure overload
O’Connell, T. D., Swigart, P. M., Rodrigo, M. C., Ishizaka, S., Joho, S., Turnbull, L., Tecott, L. H., Baker, A. J., Foster, E., Grossman, W., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci22811 · Cited by 152
Villacorta, L., Zhang, J., Garcia-Barrio, M. T., Chen, X.-L., Freeman, B. A., Chen, Y. E., & Cui, T. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00261.2007 · Cited by 144
Self-citationQin, F., Simeone, M., & Patel, R. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.04.021 · Cited by 141
Heme Oxygenase-1 Inhibits Angiotensin II-Induced Cardiac Hypertrophy In Vitro and In Vivo
Hu, C.-M., Chen, Y., Chiang, M., & Chau, L. (2004) · Circulation · doi:10.1161/01.cir.0000135475.35758.23 · Cited by 140
Zhu, H., Jia, Z., Misra, B. R., Zhang, L., Cao, Z., Yamamoto, M. P., Trush, M. A., Misra, H. P., & Li, Y. (2008) · Cardiovascular Toxicology · doi:10.1007/s12012-008-9016-0 · Cited by 139
Self-citationLi, N., & Nel, A. E. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.88 · Cited by 130
Lu, Z., Xu, X., Hu, X., Zhu, G., Zhang, P., van Deel, E. D., French, J. P., Fassett, J., Oury, T. D., Bache, R. J., et al. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.098186 · Cited by 119
Matsushima, S., Kinugawa, S., Ide, T., Matsusaka, H., Inoue, N., Ohta, Y., Yokota, T., Sunagawa, K., & Tsutsui, H. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00427.2006 · Cited by 108
Ruhparwar, A. (2008) · Circulation · doi:10.1161/circulationaha.107.188511 · Cited by 108
Ha, T., Hua, F., Li, Y., Ma, J., Gao, X., Kelley, J., Zhao, A., Haddad, G. E., Williams, D. L., Browder, I. W., et al. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00720.2005 · Cited by 103
Wiesel, P., Patel, A. P., Carvajal, I. M., Wang, Z. Y., Pellacani, A. U. E., Maemura, K., DiFonzo, N., Rennke, H. G., Layne, M. D., Yet, S., et al. (2001) · Circulation Research · doi:10.1161/hh1001.091521 · Cited by 101
Hypertension and sudden cardiac death
Messerli, F. H. (1999) · American Journal of Hypertension · doi:10.1016/s0895-7061(99)00106-5 · Cited by 92
Nakamura, A., Rokosh, G. D., Paccanaro, M., Yee, R. R., Simpson, P. C., Grossman, W., & Foster, E. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.281.3.h1104 · Cited by 89
Koide, M., Nagatsu, M., Zile, M. R., Hamawaki, M., Swindle, M. M., Keech, G. B., DeFreyte, G., Tagawa, H., Cooper, G., & Carabello, B. A. (1997) · Circulation · doi:10.1161/01.cir.95.6.1601 · Cited by 87
Omiya, S., Hikoso, S., Imanishi, Y., Saito, A., Yamaguchi, O., Takeda, T., Mizote, I., Oka, T., Taneike, M., Nakano, Y., et al. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.09.714 · Cited by 71
Effects of collagen density on cardiac fibroblast behavior and gene expression
Loftis, M. J., Sexton, D., & Carver, W. E. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10330 · Cited by 44
Cited by
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
Cuadrado, A., Rojo, A. I., Wells, G., Hayes, J. D., Cousin, S. P., Rumsey, W. L., Attucks, O. C., Franklin, S., Levonen, A.-L., Kensler, T. W., et al. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-018-0008-x · Cited by 1,438
The complexity of the Nrf2 pathway: beyond the antioxidant response
Huang, Y., Li, W., Su, Z.-Y., & Kong, A.-N. T. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.08.001 · Cited by 445
Mitochondria and Cardiovascular Aging
Dai, D.-F., Rabinovitch, P. S., & Ungvari, Z. (2012) · Circulation Research · doi:10.1161/circresaha.111.246140 · Cited by 439
Tan, Y., Ichikawa, T., Li, J., Si, Q., Yang, H., Chen, X., Goldblatt, C. S., Meyer, C. J., Li, X., Cai, L., et al. (2011) · Diabetes · doi:10.2337/db10-1164 · Cited by 392
Self-citationGo, Y.-M., Chandler, J. D., & Jones, D. P. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.03.022 · Cited by 336
Metadata
- Authors
- Li, J., Ichikawa, T., Villacorta, L., Janicki, J. S., Brower, G. L., Yamamoto, M., & Cui, T.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2009-11
- Volume
- 29
- Issue
- 11
- Pages
- 1843-1850
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2052472486
- Cited by
- 253
- References
- 47
- FWCI
- 3.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.